AI-Based Breathalyzer Can Electronically `Smell` Coronavirus and Detect Infection in Under Two Minutes
By LabMedica International staff writers Posted on 07 Jan 2021 |
Image: GeNose C19 (Photo courtesy of Gadjah Mada University)
A simple breathalyser test uses artificial intelligence (AI) to electronically "smell' the novel coronavirus and detect infection in less than two minutes.
Scientists at the Gadjah Mada University (Jogjakarta, Indonesia) have developed the GeNose C19 or Gadjah Mada Electronic Nose that rapidly detects COVID-19 using only a person’s breath. The electronic-based diagnostic tool uses the cloud computing system to deliver real-time diagnosis results and can also be run in parallel through a centralized diagnostic process to maintain data validity for all connected devices.
The device uses powerful filters and suction to remove all COVID-19 droplets or particles and sterilize itself for the next test. GeNose C19 offers the advantages of lower cost per test, instant test results, ease of mass production, and high specificity and sensitivity. The Indonesian government has granted a distribution permit for GeNose C19 which is already being used to screen patients for COVID-19 by three hospitals across the country.
"We need faster screening to prevent people getting infected," said Bambang Brodjonegoro, Indonesia's Minister for Research and Technology. "This will accelerate the detection process and mitigate the risk of the pandemic spreading."
Related Links:
Gadjah Mada University
Scientists at the Gadjah Mada University (Jogjakarta, Indonesia) have developed the GeNose C19 or Gadjah Mada Electronic Nose that rapidly detects COVID-19 using only a person’s breath. The electronic-based diagnostic tool uses the cloud computing system to deliver real-time diagnosis results and can also be run in parallel through a centralized diagnostic process to maintain data validity for all connected devices.
The device uses powerful filters and suction to remove all COVID-19 droplets or particles and sterilize itself for the next test. GeNose C19 offers the advantages of lower cost per test, instant test results, ease of mass production, and high specificity and sensitivity. The Indonesian government has granted a distribution permit for GeNose C19 which is already being used to screen patients for COVID-19 by three hospitals across the country.
"We need faster screening to prevent people getting infected," said Bambang Brodjonegoro, Indonesia's Minister for Research and Technology. "This will accelerate the detection process and mitigate the risk of the pandemic spreading."
Related Links:
Gadjah Mada University
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants